Dr MSc - EnGene Holdings Chief Officer
| ENGN Etf | USD 6.92 1.04 17.69% |
| Age | 45 |
| Address | 4868 Rue Levy, Montreal, QC, Canada, H4R 2P1 |
| Phone | 514 332 4888 |
| Web | https://www.engene.com |
EnGene Holdings Management Efficiency
The company has return on total asset (ROA) of (0.2207) % which means that it has lost $0.2207 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2306) %, meaning that it created substantial loss on money invested by shareholders. EnGene Holdings' management efficiency ratios could be used to measure how well EnGene Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Found 9 records | One Year Return | ||
| Caroline Chevalier | Zenas BioPharma, Common | N/A | |
| Orlando Oliveira | Zenas BioPharma, Common | 48 | |
| Jeffrey Held | Zenas BioPharma, Common | 55 | |
| Errol Samuelson | Zillow Group Class | 58 | |
| Jun Choo | Zillow Group Class | N/A | |
| Bradley Berning | Zillow Group Class | N/A | |
| Jeremy Hofmann | Zillow Group Class | 37 | |
| David Beitel | Zillow Group Class | 54 | |
| Jenny Arden | Zillow Group Class | N/A | |
Management Performance
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.22 |
enGene Holdings Common Money Managers
| DSc FRSC, CoFounder Board | ||
| Joan Connolly, Chief Officer | ||
| Anthony Cheung, CoFounder Officer | ||
| Raj MD, Chief Officer | ||
| JD Esq, CEO Director | ||
| Ronald Cooper, Chief Director | ||
| Alex Nichols, President COO | ||
| Dr MSc, Chief Officer | ||
| David Daws, CFO Development | ||
| MBChB MFPM, Chief Officer | ||
| Lee Giguere, Chief Secretary | ||
| FACS MD, Chief Officer | ||
| Sharon Tan, VP Management | ||
| Paul Erickson, NonExecutive Director |
EnGene Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is EnGene Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 71 M | ||||
| Shares Outstanding | 50.98 M | ||||
| Shares Owned By Insiders | 13.61 % | ||||
| Shares Owned By Institutions | 83.23 % | ||||
| Number Of Shares Shorted | 768.33 K | ||||
| Price To Book | 1.32 X | ||||
| EBITDA | (94.77 M) | ||||
| Net Income | (99.92 M) |
Pair Trading with EnGene Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnGene Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will appreciate offsetting losses from the drop in the long position's value.Moving against EnGene Etf
| 0.38 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.37 | VINC | Vincerx Pharma | PairCorr |
| 0.33 | A | Agilent Technologies | PairCorr |
The ability to find closely correlated positions to EnGene Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnGene Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnGene Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enGene Holdings Common to buy it.
The correlation of EnGene Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnGene Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enGene Holdings Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnGene Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in EnGene Etf
EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.